Andrew G.

Thanks for including my list of book recommendations on this compilation. I just added a few more recent highlights (now >100 titles): amazon.com/shop/bioduedil…

@tylermilliken_ Of course he pinch hit for one of the only other ones that gets hits

Ceddanne Rafaela is now rocking a 111 wRC+. Didn't see much power to start the season, but now he's clicking on that front too. If he can consistently tap into that HR power with his BB% and Chase% continuing to trend in the right direction, we're cooking.

@Clarksterh There is a fair amount of detail released: fda.gov/media/192160/d…

Company appears to have adjusted the data after unblinding and database lock (presumably wo telling the FDA, bc they wld have rejected it). Interesting question is how the FDA discovered it.

RT @AppleHelix: Wow this is really interesting case. Sezaby is phenobarbital sodium. Phenobarbital has been used for over 100 years. There…

I'm sad to learn that J. Craig Venter, a key figure in modern genomics and an inveterate troublemaker, passed away. Craig was very important to the study of human genetics and the biotechnology industry. He also had an impact on my career. The pitch that led @michaelnoer to hire

Woke up to a text from a former Red Sox player who summed up Saturday's moves: 'It's like shitting your pants and changing your shirt.'

The Orioles hit so many home runs off the Red Sox tonight that they ran out of fireworks in Baltimore. This is a real tweet.

@Section10Pod @Jared_Carrabis Hits

What’s one thing you can’t get at Fenway that you wish you could? New Clean 40 is on our Patreon now: patreon.com/section10podca…

I'm so excited for @Mykalt45. Congrats!

@Mykalt45 @CrossBridgeBio Congrats!

Super excited to announce this! Proud of what we built at @CrossBridgeBio! Personally rewarding especially as my dad passed away in January of this year. His birthday was 4/7. Tried to close on that day! businesswire.com/news/home/2026…

@chrissyfarr Congrats! I would have thought my podcast consumption was fairly routine (car commute, dog walks, winding down in bed), but I guess not because none of that translates to a time where I have any interest in a video version

Video is everything. We shifted our pod from audio only to video and now we are about to hit our millionth download since January. Growth has been astonishing.

@SarahKarlin @AlecGaffney @Filmoreorless Second ‘white oak’ moniker in a year: whiteoakregtox.com

This is one of the more interesting FDA-industry revolving door items I've seen via @AlecGaffney @Filmoreorless ex-CDRH Director JEFF SHUREN, Deputy Director DOUG KELLY and Chief Scientist RUSTY SEGAN, are starting a new medtech venture capital fund White Oak 66 Capital

RT @michaelFhurley: You’ve heard of turning two but betcha haven’t heard of turning zero

The idea that you can take phase 1 and 2 China data to FDA and use it to get approval to start a phase 3 is simply not true. It’s not even partially incorrect. It is completely and utterly false. Comically so. And if one’s analysis of what the advantage China has in drug discovery and development is to come up with a false explanation, good luck catching up.

Congrats to Denali for their FDA Approval of AVLAYAH! Fun bit of biotech history. The bi-specific shuttle technology used in Avlayah came from F-star, a European biotech we helped seed in 2006 (thx Regina Hodits). They were advancing a bi-specific mAb format for a range of

@Jared_Carrabis Maybe to shit on Marcelo a little more while Durbin and Story screw up defensively

He’s there to extend Roman Anthony’s extension I do believe.

@Archimedes20311 Amazing Ouro bought that asset for $16M up front in Nov 2024 from Keymed Biosciences so 1.5 years later flipped it for $1.675B! 100x return! www1.hkexnews.hk/listedco/listc…

@1nvestorGadget @AlecGaffney @drrichjlaw @adamfeuerstein Yeah that seems crazy, especially when combined with a (likely) massive pay cut

FDA is officially looking to hire a new Director of its Center for Biologics Evaluation and Research (CBER), and now you can see the full list of qualifications. Would replace the outgoing director, Vinay Prasad, who is leaving at the end of April. The agency is also looking for a second Deputy Director of CBER : (usajobs.gov/job/860827200) We haven't yet seen FDA post about hiring a new Chief Scientific/Medical Officer, which is the other position held by Prasad.

FDA kind of buried this news earlier, but it's planning to hold a public hearing in June to solicit feedback about its Commissioner's National Priority Voucher program. Going to be a popular meeting, I'm sure. fda.gov/news-events/pr…

STAT FDA reporter @LizzyLaw_ asks HHS chief counselor Chris Klomp about the turnover at the FDA. Klomp: “When I see turnover in any organization — could be the FDA, it could be another — it's worrisome…” #STATBreakthrough

On the results of preclinical biotech programs that received the largest upfront cash payments from '10-'15: "High upfronts were a signal that someone felt urgency to act, not that the program was more likely to succeed."